Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Newly admitted paranoid schizophrenic patients (N = 68) were treated with either loxapine or chlorpromazine for up to 4 weeks. Mean maximum dosages were 84 mg/day of loxapine and 820 mg/day of chlorpromazine. Loxapine showed efficacy superior to that of chlorpromazine, confirming earlier retrospective findings. Adverse reactions were also less troublesome with loxapine.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on